TWO SIGMA ADVISERS, LP - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPH and the CUSIP is 88165N204. A total of 23 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q4 2019$30,000
-55.9%
10,774
-16.3%
0.00%
Q3 2019$68,00012,8740.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q4 2019
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 149,507$420,0000.02%
Tekla Capital Management LLC 42,965$121,0000.01%
OXFORD ASSET MANAGEMENT LLP 28,435$80,0000.00%
UBS Group AG 2,900$8,0000.00%
Sowell Financial Services LLC 1$00.00%
FMR LLC 3$00.00%
DIMENSIONAL FUND ADVISORS LP 20,068$56,0000.00%
BANK OF AMERICA CORP /DE/ 7,099$20,0000.00%
FLAGSHIP HARBOR ADVISORS, LLC 465$1,0000.00%
Russell Investments Group, Ltd. 62,131$174,0000.00%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders